CORRIGAN MARK Insider Trading

Get the latest insider transactions of CORRIGAN MARK. CORRIGAN MARK is Executive VP, R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive, VP R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Director in NOVELION THERAPEUTICS INC. ($QLTI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and Director in Wave Life Sciences Ltd. ($WVE) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV). Discover the current value of CORRIGAN MARK shares.

Address: 84 WATERFORD DRIVE MARLBOROUGH 01752MA

CORRIGAN MARK is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
SEPRSunovion Pharmaceuticals Inc.Executive, VP R&D, Executive VP, R&D00.00
CRXXEPIRUS Biopharmaceuticals, Inc.Director00.00
CLCDCoLucid Pharmaceuticals, Inc.Director00.00
NVLNNOVELION THERAPEUTICS INC.Director00.00
NBRVNabriva Therapeutics Legacy plcDirector0
NBRVNabriva Therapeutics plcDirector00.00
WVEWave Life Sciences Ltd.Director00.00

Insider Trading Transactions of CORRIGAN MARK

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Aug 20 2020WVEWave Life Sciences Ltd.CORRIGAN MARKDirectorOption Exercise9.1310,50095,86510,500
Sep 06 2019WVEWave Life Sciences Ltd.CORRIGAN MARKDirectorOption Exercise21.0321,000441,63021,000
Aug 01 2019NBRVNabriva Therapeutics plcCORRIGAN MARKDirectorOption Exercise0.0035,000035,000
Aug 13 2018NVLNNOVELION THERAPEUTICS INC ...CORRIGAN MARKDirectorOption Exercise3.3350,000166,50050,000
May 04 2018NBRVNabriva Therapeutics plcCORRIGAN MARKDirectorOption Exercise0.0029,000029,000
Sep 19 2017NBRVNabriva Therapeutics plcCORRIGAN MARKDirectorOption Exercise0.0010,100010,100
Jun 27 2017NBRVNabriva Therapeutics PlcCORRIGAN MARKDirectorOption Exercise0.0020,200020,200
Jun 27 2017NBRVNabriva Therapeutics PlcCORRIGAN MARKDirectorOption Exercise0.0010,100010,100
Mar 31 2017QLTINOVELION THERAPEUTICS INC ...CORRIGAN MARKDirectorOption Exercise10.649,600102,1449,600
Mar 01 2017CLCDCoLucid Pharmaceuticals, ...CORRIGAN MARKDirectorOption Exercise3.798,11430,7520
Mar 01 2017CLCDCoLucid Pharmaceuticals, ...CORRIGAN MARKDirectorOption Exercise6.248,89755,5170
May 12 2016CLCDCoLucid Pharmaceuticals, ...CORRIGAN MARKDirectorOption Exercise6.248,89755,5178,897
Oct 29 2015CLCDCoLucid Pharmaceuticals, ...CORRIGAN MARKDirectorOption Exercise3.798,11430,7528,114
Jun 08 2015CRXXEPIRUS Biopharmaceuticals ...CORRIGAN MARKDirectorOption Exercise6.399,00057,5109,000
Oct 22 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell23.0070,6681,625,3640
Oct 22 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DOption Exercise16.7870,0001,174,6000
Oct 22 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DOption Exercise21.2642,165896,4280
Oct 22 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DOption Exercise14.4057,500828,0000
Oct 19 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell23.0020,749477,22770,668
May 14 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DBuy14.4035,000504,00091,417
May 14 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DOption Exercise14.4057,500828,00057,500
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.515006,75561,400
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.521001,35261,300
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.572002,71461,100
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.61911,23961,009
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.623094,20960,700
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.694005,47660,300
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.716008,22659,700
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.723004,11659,400
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.735006,86558,900
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.743004,12258,600
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.753004,12558,300
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.764005,50457,900
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.804005,52057,500
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.813004,14357,200
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.82831,14757,117
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.833004,14956,817
May 05 2009SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell13.864005,54456,417
Jun 05 2008SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell20.9256811,88366,832
Jun 05 2008SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell20.931,83238,34465,000
Jun 05 2008SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DSell20.943,10064,91461,900
May 22 2008SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DBuy21.2635,000744,10067,400
May 22 2008SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DOption Exercise21.2642,165896,42842,165
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.975,150241,896147,068
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.982,00093,960145,068
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.992,234104,976142,834
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.003,884182,548138,950
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.013,300155,133135,650
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.025,400253,908130,250
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.031,65077,600128,600
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.041,50070,560127,100
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.051,10051,755126,000
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy47.062,288107,673123,712
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.077,081333,303116,631
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.087,321344,673109,310
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.096,248294,218103,062
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.104,671220,00498,391
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.114,691220,99393,700
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.122,10098,95291,600
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.132,200103,68689,400
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.142,532119,35886,868
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.154,400207,46082,468
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.163,468163,55179,000
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.172,200103,77476,800
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.182,200103,79674,600
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.193,726175,83070,874
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.203,136148,01967,738
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.213,661172,83664,077
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.222,203104,02661,874
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.232,854134,79459,020
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.242,220104,87356,800
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.257,385348,94149,415
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.265,005236,53644,410
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.272,500118,17541,910
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.281,00047,28040,910
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.2960028,37440,310
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3032015,13639,990
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3140018,92439,590
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3228013,25039,310
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3380037,86438,510
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3450023,67038,010
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3530014,20537,710
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.36301,42137,680
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3760028,42237,080
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.382009,47636,880
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.3990042,65135,980
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.403,000142,20032,980
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.412009,48232,780
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell47.4238018,02032,400
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy16.78140,0002,349,200172,400
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy27.7040,0001,108,000212,400
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.6730014,001212,100
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.681004,668212,000
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.691,60074,704210,400
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.7060028,020209,800
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.7180037,368209,000
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.7250023,360208,500
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.7330014,019208,200
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy46.752,10098,175206,100
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.7647322,117205,627
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.772,318108,413203,309
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.781,74081,397201,569
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.791,20956,569200,360
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.802,560119,808197,800
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.812,540118,897195,260
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.823,500163,870191,760
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy46.834,103192,143187,657
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.841,90088,996185,757
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy46.851,80084,330183,957
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DBuy46.863,477162,932108,480
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.872,182102,270178,298
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.881,60075,008176,698
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.891,42566,818175,273
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.905,058237,220170,215
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.913,397159,353166,818
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.924,300201,756162,518
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.932,200103,246160,318
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.941,50070,410158,818
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DSell46.966,600309,936152,218
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DOption Exercise16.78140,0002,349,2000
Jun 15 2007SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive, VP R&DOption Exercise27.7040,0001,108,0000
Feb 11 2004SEPRSunovion Pharmaceuticals ...CORRIGAN MARKExecutive VP, R&DBuy27.70100,0002,770,0000